Search
By Reuters StaffNEW YORK (Reuters Health) - Functional brain abnormalities may explain atypical personality traits in adults with myotonic dystrophy type 1 (DM1), the most common muscular dystrophy in adults, hints new research from Italy.
Healthy weight at an early age is a powerful predictor of healthy weight in later childhood, according to the results of a new study.
Childhood obesity continues to grow in prevalence. Authors of a new study evaluated the factors that affect the success of weight management among children who visited an obesity management clinic.
Understanding characteristics associated with discontinuation of biologic therapy in patients with severe asthma is necessary to help to address barriers to treatment success in this population. Test your knowledge by taking our quiz.
The FDA approved two gene therapies, the first of their kind, to treat patients aged 12 years and older with sickle cell disease.
A physician’s ability to recognize depression depends almost entirely upon their interactions and communication with patients.
Two new studies explored the impact of exercise on patients with atrial fibrillation.
By Lisa RapaportNEW YORK (Reuters Health) - Heart failure patients may exercise more when they have support from family and friends, a U.S. study suggests.
Here is our breakdown of this month’s biggest stories on infectious diseases, treatments, and recommendations.
A recent study assessed the safety of use of the live attenuated influenza vaccine in younger patients with egg allergies.
New research examined the categorical and quantitative dose-response association between sedentary behavior and CVD risk.
Depressive symptoms, including depressed mood and anhedonia, in adolescents remain consistent across symptom subgroups and time, but vary according to intersection identities, says new research published in the Journal of Affective Disorders.
Nutrition411 spoke with Jo Ann Carson, PhD, RDN, about the American Heart Association’s latest science advisory on dietary cholesterol and cardiovascular risk, which was published in Circulation. February is American Heart Month.
Recently, therapy to reduce PCSK9 activity has been approved for use in those with cardiovascular disease who require additional LDL-C lowering despite the use of maximally tolerated statins.
In this podcast, Alan S. Go, MD, discusses the results of his recent study, which examined the relationship between HIV, heart failure, and patient demographics.
Jessica Bard: Hello everyone, and welcome to another installment of Podcasts360, your go‑to resource for medical news and clinical updates. I'm your moderator, Jessica Bard with Consultant360 Specialty Network.